Your browser doesn't support javascript.
Genomic Surveillance for SARS-CoV-2 Variants of Concern from Imported COVID-19 Cases - the Mainland of China, 2021.
Feng, Yenan; Zhao, Xiang; Chen, Zhixiao; Nie, Kai; Yin, Zeyuan; Xia, Ying; Wang, Ji; Niu, Peihua; A, Ruhan; Li, Lili; Wang, Dayan; Tan, Wenjie; Ma, Xuejun; Wang, Shiwen; Wang, Huanyu; Gao, George F; Chen, Cao; Xu, Wenbo.
  • Feng Y; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Zhao X; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
  • Chen Z; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Nie K; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
  • Yin Z; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xia Y; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang J; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
  • Niu P; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • A R; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Li L; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang D; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
  • Tan W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Ma X; National Health Commission Key Laboratory for Medical Virology and Viral Diseases, Beijing, China.
  • Wang S; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Wang H; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Gao GF; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Chen C; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Xu W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
China CDC Wkly ; 4(31): 680-684, 2022 Aug 05.
Article in English | MEDLINE | ID: covidwho-1989061
ABSTRACT

Introduction:

After the epidemic in Wuhan City was brought under control in 2020, local outbreaks of coronavirus disease 2019 (COVID-19) in the mainland of China were mainly due to imported COVID-19 cases. The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to generate new variants. Some have been designated as variants of concern (VOCs) by the World Health Organization (WHO). To better assess the role of imported SARS-CoV-2 surveillance and the prevalence of VOCs in 2021, the genomic surveillance data of SARS-CoV-2 from imported COVID-19 cases of 2021 in the mainland of China were analyzed.

Methods:

The analyses included the number of sequence submissions, time of sequence deposition, and time of detection of the VOCs in order to determine the timeliness and sensitivity of the surveillance. The proportions of VOCs were analyzed and compared with data from the Global Initiative of Sharing All Influenza Data (GISAID).

Results:

A total of 3,355 sequences of imported cases were submitted from 29 provincial-level administrative divisions, with differences in the number of sequence submissions and median time of sequence deposition. A total of 2,388 sequences with more than 90% genomic coverage were used for lineage analysis. The epidemic trend from Alpha to Delta to Omicron in imported cases was consistent with that in the GISAID. In addition, VOCs from imported cases were usually identified after WHO designation and before causing local outbreaks.

Conclusions:

The global distribution of SARS-CoV-2 VOCs changed rapidly in 2021. Robust genomic surveillance of the imported SARS-CoV-2 in the mainland of China is of great significance.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Observational study Topics: Variants Language: English Journal: China CDC Wkly Year: 2022 Document Type: Article Affiliation country: Ccdcw2022.144

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Diagnostic study / Experimental Studies / Observational study Topics: Variants Language: English Journal: China CDC Wkly Year: 2022 Document Type: Article Affiliation country: Ccdcw2022.144